Citizens Financial Group Inc Eliem Therapeutics, Inc. Transaction History
Citizens Financial Group Inc
- $7.13 Billion
- Q3 2025
A detailed history of Citizens Financial Group Inc transactions in Eliem Therapeutics, Inc. stock. As of the latest transaction made, Citizens Financial Group Inc holds 46,000 shares of ELYM stock, worth $189,060. This represents 0.0% of its overall portfolio holdings.
Number of Shares
46,000Holding current value
$189,060% of portfolio
0.0%Shares
1 transactions
Others Institutions Holding ELYM
# of Institutions
69Shares Held
47.8MCall Options Held
0Put Options Held
0-
Ra Capital Management, L.P. Boston, MA31.4MShares$129 Million2.82% of portfolio
-
Cantor Fitzgerald, L. P. New York, NY2.5MShares$10.3 Million0.01% of portfolio
-
Affinity Asset Advisors, LLC New York, NY1.5MShares$6.17 Million1.03% of portfolio
-
Vanguard Group Inc Valley Forge, PA1.32MShares$5.41 Million0.0% of portfolio
-
Deep Track Capital, LP Greenwich, CT1.04MShares$4.27 Million0.15% of portfolio
About Eliem Therapeutics, Inc.
- Ticker ELYM
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 26,567,700
- Market Cap $109M
- Description
- Eliem Therapeutics, Inc., a clinical-stage biotechnology company, focuses on developing therapies for neuronal excitability disorders to address unmet needs in chronic pain, neuropsychiatry, epilepsy, and other disorders of the peripheral and central nervous systems. Its two lead drug candidates are ETX-810 for chronic pain, which is in Phase II...